https://www.selleckchem.com/pr....oducts/CI-1040-(PD18
collection is expected to be completed in 2026. By collecting data on the long-term (cost-)effectiveness of the MR-HIFU treatment in comparison to current standard fibroid care, we provide currently unavailable evidence about the proper place of MR-HIFU in the fibroid treatment spectrum. This will also facilitate reimbursement and inclusion of MR-HIFU in (inter)national uterine fibroid care guidelines. Netherlands Trial Register NL8863; https//www.trialregister.nl/trial/8863. DERR1-10.2196/29467. DERR1-10.2196/29467. Digital
Like
Comment
Share
